Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment.
Jie-Zuan YangHaifeng LuBaikun ChenLili JiangHua ZhangPing YeLinfeng JinPublished in: Journal of immunology research (2023)
The predictive cutoff value of ALT for HBeAg SC was 178 U/L at baseline. Moreover, the ALT, Treg, and TRBV families would be associated with the prognosis and pathogenesis of CHB patients during TDF treatment.